慢性呼吸器疾患治療のグローバル市場展望 2023年-2029年：コルチコステロイド、気管支拡張剤、モノクローナル抗体、抗生物質、粘液溶解剤、ロイコトリエン修飾薬、その他

■ 英語タイトル：Chronic Respiratory Diseases Treatment Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8418）

■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8418
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：73
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[慢性呼吸器疾患治療のグローバル市場展望 2023年-2029年：コルチコステロイド、気管支拡張剤、モノクローナル抗体、抗生物質、粘液溶解剤、ロイコトリエン修飾薬、その他]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の慢性呼吸器疾患治療市場規模と予測を収録しています。・世界の慢性呼吸器疾患治療市場：売上、2018年-2023年、2024年-2029年
・世界の慢性呼吸器疾患治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の慢性呼吸器疾患治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「コルチコステロイド」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

慢性呼吸器疾患治療のグローバル主要企業は、Mylan、 Teva Pharmaceutical、 Sumitomo Dainippon Pharma、 Merck、 Boehringer Ingelheim Pharmaceuticals、 AstraZeneca、 GlaxoSmithKlineなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、慢性呼吸器疾患治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の慢性呼吸器疾患治療市場：タイプ別、2018年-2023年、2024年-2029年
世界の慢性呼吸器疾患治療市場：タイプ別市場シェア、2022年
・コルチコステロイド、気管支拡張剤、モノクローナル抗体、抗生物質、粘液溶解剤、ロイコトリエン修飾薬、その他

世界の慢性呼吸器疾患治療市場：用途別、2018年-2023年、2024年-2029年
世界の慢性呼吸器疾患治療市場：用途別市場シェア、2022年
・小売薬局、病院薬局、通信販売薬局

世界の慢性呼吸器疾患治療市場：地域・国別、2018年-2023年、2024年-2029年
世界の慢性呼吸器疾患治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における慢性呼吸器疾患治療のグローバル売上、2018年-2023年
・主要企業における慢性呼吸器疾患治療のグローバル売上シェア、2022年
・主要企業における慢性呼吸器疾患治療のグローバル販売量、2018年-2023年
・主要企業における慢性呼吸器疾患治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Mylan、 Teva Pharmaceutical、 Sumitomo Dainippon Pharma、 Merck、 Boehringer Ingelheim Pharmaceuticals、 AstraZeneca、 GlaxoSmithKline

*************************************************************

・調査・分析レポートの概要
慢性呼吸器疾患治療市場の定義
市場セグメント
世界の慢性呼吸器疾患治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の慢性呼吸器疾患治療市場規模
世界の慢性呼吸器疾患治療市場規模：2022年 VS 2029年
世界の慢性呼吸器疾患治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの慢性呼吸器疾患治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の慢性呼吸器疾患治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：コルチコステロイド、気管支拡張剤、モノクローナル抗体、抗生物質、粘液溶解剤、ロイコトリエン修飾薬、その他
慢性呼吸器疾患治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：小売薬局、病院薬局、通信販売薬局
慢性呼吸器疾患治療の用途別グローバル売上・予測

・地域別市場分析
地域別慢性呼吸器疾患治療市場規模 2022年と2029年
地域別慢性呼吸器疾患治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Mylan、 Teva Pharmaceutical、 Sumitomo Dainippon Pharma、 Merck、 Boehringer Ingelheim Pharmaceuticals、 AstraZeneca、 GlaxoSmithKline
...

The chronic respiratory diseases are the diseases that have adverse effects on the respiratory organs. The list of chronic respiratory diseases includes asthma, occupational lung diseases, pulmonary fibrosis, chronic obstructive pulmonary disease, chronic sinusitis, and others. These diseases have no cure but are treatable.
This report aims to provide a comprehensive presentation of the global market for Chronic Respiratory Diseases Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Respiratory Diseases Treatment. This report contains market size and forecasts of Chronic Respiratory Diseases Treatment in global, including the following market information:
Global Chronic Respiratory Diseases Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Chronic Respiratory Diseases Treatment Market Sales, 2018-2023, 2024-2029, (K Tablets)
Global top five Chronic Respiratory Diseases Treatment companies in 2022 (%)
The global Chronic Respiratory Diseases Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Corticosteroids Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Chronic Respiratory Diseases Treatment include Mylan, Teva Pharmaceutical, Sumitomo Dainippon Pharma, Merck, Boehringer Ingelheim Pharmaceuticals, AstraZeneca and GlaxoSmithKline, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Respiratory Diseases Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Respiratory Diseases Treatment Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Tablets)
Global Chronic Respiratory Diseases Treatment Market Segment Percentages, by Type, 2022 (%)
Corticosteroids
Bronchodilators
Monoclonal Antibodies
Antibiotics
Mucolytic Agents
Leukotriene Modifiers
Others
Global Chronic Respiratory Diseases Treatment Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Tablets)
Global Chronic Respiratory Diseases Treatment Market Segment Percentages, by Application, 2022 (%)
Retail Pharmacies
Hospital Pharmacies
Mail Order Pharmacies
Global Chronic Respiratory Diseases Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Tablets)
Global Chronic Respiratory Diseases Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Respiratory Diseases Treatment revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Chronic Respiratory Diseases Treatment revenues share in global market, 2022 (%)
Key companies Chronic Respiratory Diseases Treatment sales in global market, 2018-2023 (Estimated), (K Tablets)
Key companies Chronic Respiratory Diseases Treatment sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mylan
Teva Pharmaceutical
Sumitomo Dainippon Pharma
Merck
Boehringer Ingelheim Pharmaceuticals
AstraZeneca
GlaxoSmithKline
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chronic Respiratory Diseases Treatment, market overview.
Chapter 2: Global Chronic Respiratory Diseases Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Chronic Respiratory Diseases Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chronic Respiratory Diseases Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Chronic Respiratory Diseases Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Chronic Respiratory Diseases Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Respiratory Diseases Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Respiratory Diseases Treatment Overall Market Size
2.1 Global Chronic Respiratory Diseases Treatment Market Size: 2022 VS 2029
2.2 Global Chronic Respiratory Diseases Treatment Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Chronic Respiratory Diseases Treatment Sales: 2018-2029
3 Company Landscape
3.1 Top Chronic Respiratory Diseases Treatment Players in Global Market
3.2 Top Global Chronic Respiratory Diseases Treatment Companies Ranked by Revenue
3.3 Global Chronic Respiratory Diseases Treatment Revenue by Companies
3.4 Global Chronic Respiratory Diseases Treatment Sales by Companies
3.5 Global Chronic Respiratory Diseases Treatment Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Chronic Respiratory Diseases Treatment Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Chronic Respiratory Diseases Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chronic Respiratory Diseases Treatment Players in Global Market
3.8.1 List of Global Tier 1 Chronic Respiratory Diseases Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Chronic Respiratory Diseases Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Chronic Respiratory Diseases Treatment Market Size Markets, 2022 & 2029
4.1.2 Corticosteroids
4.1.3 Bronchodilators
4.1.4 Monoclonal Antibodies
4.1.5 Antibiotics
4.1.6 Mucolytic Agents
4.1.7 Leukotriene Modifiers
4.1.8 Others
4.2 By Type – Global Chronic Respiratory Diseases Treatment Revenue & Forecasts
4.2.1 By Type – Global Chronic Respiratory Diseases Treatment Revenue, 2018-2023
4.2.2 By Type – Global Chronic Respiratory Diseases Treatment Revenue, 2024-2029
4.2.3 By Type – Global Chronic Respiratory Diseases Treatment Revenue Market Share, 2018-2029
4.3 By Type – Global Chronic Respiratory Diseases Treatment Sales & Forecasts
4.3.1 By Type – Global Chronic Respiratory Diseases Treatment Sales, 2018-2023
4.3.2 By Type – Global Chronic Respiratory Diseases Treatment Sales, 2024-2029
4.3.3 By Type – Global Chronic Respiratory Diseases Treatment Sales Market Share, 2018-2029
4.4 By Type – Global Chronic Respiratory Diseases Treatment Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Chronic Respiratory Diseases Treatment Market Size, 2022 & 2029
5.1.2 Retail Pharmacies
5.1.3 Hospital Pharmacies
5.1.4 Mail Order Pharmacies
5.2 By Application – Global Chronic Respiratory Diseases Treatment Revenue & Forecasts
5.2.1 By Application – Global Chronic Respiratory Diseases Treatment Revenue, 2018-2023
5.2.2 By Application – Global Chronic Respiratory Diseases Treatment Revenue, 2024-2029
5.2.3 By Application – Global Chronic Respiratory Diseases Treatment Revenue Market Share, 2018-2029
5.3 By Application – Global Chronic Respiratory Diseases Treatment Sales & Forecasts
5.3.1 By Application – Global Chronic Respiratory Diseases Treatment Sales, 2018-2023
5.3.2 By Application – Global Chronic Respiratory Diseases Treatment Sales, 2024-2029
5.3.3 By Application – Global Chronic Respiratory Diseases Treatment Sales Market Share, 2018-2029
5.4 By Application – Global Chronic Respiratory Diseases Treatment Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Chronic Respiratory Diseases Treatment Market Size, 2022 & 2029
6.2 By Region – Global Chronic Respiratory Diseases Treatment Revenue & Forecasts
6.2.1 By Region – Global Chronic Respiratory Diseases Treatment Revenue, 2018-2023
6.2.2 By Region – Global Chronic Respiratory Diseases Treatment Revenue, 2024-2029
6.2.3 By Region – Global Chronic Respiratory Diseases Treatment Revenue Market Share, 2018-2029
6.3 By Region – Global Chronic Respiratory Diseases Treatment Sales & Forecasts
6.3.1 By Region – Global Chronic Respiratory Diseases Treatment Sales, 2018-2023
6.3.2 By Region – Global Chronic Respiratory Diseases Treatment Sales, 2024-2029
6.3.3 By Region – Global Chronic Respiratory Diseases Treatment Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Chronic Respiratory Diseases Treatment Revenue, 2018-2029
6.4.2 By Country – North America Chronic Respiratory Diseases Treatment Sales, 2018-2029
6.4.3 US Chronic Respiratory Diseases Treatment Market Size, 2018-2029
6.4.4 Canada Chronic Respiratory Diseases Treatment Market Size, 2018-2029
6.4.5 Mexico Chronic Respiratory Diseases Treatment Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Chronic Respiratory Diseases Treatment Revenue, 2018-2029
6.5.2 By Country – Europe Chronic Respiratory Diseases Treatment Sales, 2018-2029
6.5.3 Germany Chronic Respiratory Diseases Treatment Market Size, 2018-2029
6.5.4 France Chronic Respiratory Diseases Treatment Market Size, 2018-2029
6.5.5 U.K. Chronic Respiratory Diseases Treatment Market Size, 2018-2029
6.5.6 Italy Chronic Respiratory Diseases Treatment Market Size, 2018-2029
6.5.7 Russia Chronic Respiratory Diseases Treatment Market Size, 2018-2029
6.5.8 Nordic Countries Chronic Respiratory Diseases Treatment Market Size, 2018-2029
6.5.9 Benelux Chronic Respiratory Diseases Treatment Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Chronic Respiratory Diseases Treatment Revenue, 2018-2029
6.6.2 By Region – Asia Chronic Respiratory Diseases Treatment Sales, 2018-2029
6.6.3 China Chronic Respiratory Diseases Treatment Market Size, 2018-2029
6.6.4 Japan Chronic Respiratory Diseases Treatment Market Size, 2018-2029
6.6.5 South Korea Chronic Respiratory Diseases Treatment Market Size, 2018-2029
6.6.6 Southeast Asia Chronic Respiratory Diseases Treatment Market Size, 2018-2029
6.6.7 India Chronic Respiratory Diseases Treatment Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Chronic Respiratory Diseases Treatment Revenue, 2018-2029
6.7.2 By Country – South America Chronic Respiratory Diseases Treatment Sales, 2018-2029
6.7.3 Brazil Chronic Respiratory Diseases Treatment Market Size, 2018-2029
6.7.4 Argentina Chronic Respiratory Diseases Treatment Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Chronic Respiratory Diseases Treatment Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Chronic Respiratory Diseases Treatment Sales, 2018-2029
6.8.3 Turkey Chronic Respiratory Diseases Treatment Market Size, 2018-2029
6.8.4 Israel Chronic Respiratory Diseases Treatment Market Size, 2018-2029
6.8.5 Saudi Arabia Chronic Respiratory Diseases Treatment Market Size, 2018-2029
6.8.6 UAE Chronic Respiratory Diseases Treatment Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Mylan
7.1.1 Mylan Company Summary
7.1.2 Mylan Business Overview
7.1.3 Mylan Chronic Respiratory Diseases Treatment Major Product Offerings
7.1.4 Mylan Chronic Respiratory Diseases Treatment Sales and Revenue in Global (2018-2023)
7.1.5 Mylan Key News & Latest Developments
7.2 Teva Pharmaceutical
7.2.1 Teva Pharmaceutical Company Summary
7.2.2 Teva Pharmaceutical Business Overview
7.2.3 Teva Pharmaceutical Chronic Respiratory Diseases Treatment Major Product Offerings
7.2.4 Teva Pharmaceutical Chronic Respiratory Diseases Treatment Sales and Revenue in Global (2018-2023)
7.2.5 Teva Pharmaceutical Key News & Latest Developments
7.3 Sumitomo Dainippon Pharma
7.3.1 Sumitomo Dainippon Pharma Company Summary
7.3.2 Sumitomo Dainippon Pharma Business Overview
7.3.3 Sumitomo Dainippon Pharma Chronic Respiratory Diseases Treatment Major Product Offerings
7.3.4 Sumitomo Dainippon Pharma Chronic Respiratory Diseases Treatment Sales and Revenue in Global (2018-2023)
7.3.5 Sumitomo Dainippon Pharma Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Chronic Respiratory Diseases Treatment Major Product Offerings
7.4.4 Merck Chronic Respiratory Diseases Treatment Sales and Revenue in Global (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Boehringer Ingelheim Pharmaceuticals
7.5.1 Boehringer Ingelheim Pharmaceuticals Company Summary
7.5.2 Boehringer Ingelheim Pharmaceuticals Business Overview
7.5.3 Boehringer Ingelheim Pharmaceuticals Chronic Respiratory Diseases Treatment Major Product Offerings
7.5.4 Boehringer Ingelheim Pharmaceuticals Chronic Respiratory Diseases Treatment Sales and Revenue in Global (2018-2023)
7.5.5 Boehringer Ingelheim Pharmaceuticals Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Chronic Respiratory Diseases Treatment Major Product Offerings
7.6.4 AstraZeneca Chronic Respiratory Diseases Treatment Sales and Revenue in Global (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Company Summary
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Chronic Respiratory Diseases Treatment Major Product Offerings
7.7.4 GlaxoSmithKline Chronic Respiratory Diseases Treatment Sales and Revenue in Global (2018-2023)
7.7.5 GlaxoSmithKline Key News & Latest Developments
8 Global Chronic Respiratory Diseases Treatment Production Capacity, Analysis
8.1 Global Chronic Respiratory Diseases Treatment Production Capacity, 2018-2029
8.2 Chronic Respiratory Diseases Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Chronic Respiratory Diseases Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chronic Respiratory Diseases Treatment Supply Chain Analysis
10.1 Chronic Respiratory Diseases Treatment Industry Value Chain
10.2 Chronic Respiratory Diseases Treatment Upstream Market
10.3 Chronic Respiratory Diseases Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chronic Respiratory Diseases Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

慢性呼吸器疾患治療のグローバル市場展望 2023年-2029年：コルチコステロイド、気管支拡張剤、モノクローナル抗体、抗生物質、粘液溶解剤、ロイコトリエン修飾薬、その他

グローバル市場調査会社